TScan Therapeutics (TCRX) Revenue (2020 - 2026)
TScan Therapeutics (TCRX) reported Revenue of $1.05 million for Q2 2026, down 65.8% from $3.08 million a year earlier but up 7.0% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Revenue (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, TScan Therapeutics' Revenue came in at $7.11 million, up 2.2% year-over-year; for FY2025, it came in at $10.33 million, up 266.7% from FY2024.
- Revenue has a five-year compound annual growth rate of 56.9% (FY2020 to FY2025).
- By year, Revenue came in at $2.82 million in FY2024 (-86.6%), $21.05 million in FY2023 (+55.5%), $13.54 million in FY2022 (+33.5%) and $10.14 million in FY2021 (+834.7%).
- Five-year quarterly Revenue spans a low of $536,000 in Q2 2024 and a high of $7.21 million in Q4 2023.
- Year over year, Revenue gained in four of the last eight quarters, with growth averaging 112.3%.
- The high point for year-over-year Revenue in five years was Q3 2021 (growth of 731.7%); the low point was Q1 2024 (a decline of 91.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $982,000 (Q1 2026), $2.57 million (Q4 2025) and $2.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | TScan Therapeutics | 40.28 Mn | 40.28 Mn | - | 1.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 982,000.00 |
| Dec 31, 2025 | 2.57 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 665,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 536,000.00 |
| Mar 31, 2024 | 566,000.00 |
| Dec 31, 2023 | 7.21 Mn |
| Sep 30, 2023 | 3.89 Mn |
| Jun 30, 2023 | 3.15 Mn |
| Mar 31, 2023 | 6.80 Mn |
| Dec 31, 2022 | 3.10 Mn |
| Sep 30, 2022 | 3.36 Mn |
| Jun 30, 2022 | 4.06 Mn |
| Mar 31, 2022 | 3.02 Mn |
| Dec 31, 2021 | 2.85 Mn |
| Sep 30, 2021 | 2.41 Mn |
API Access
TScan Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();